Cheol Ho Park & Tae-Hyun Yoo. (2022). TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. MDPI AG.
Chicago Style (17th ed.) CitationCheol Ho Park and Tae-Hyun Yoo. TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. MDPI AG, 2022.
MLA (9th ed.) CitationCheol Ho Park and Tae-Hyun Yoo. TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.